| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |